Projects per year
Personal profile
Research interests
To develop and implement advanced imaging techniques and analysis methods for the study of disease.
Research overview
My most significant contributions to brain imaging research are in the development, application and analysis of advanced MRI techniques for the study of disease, in particular, traumatic brain injury (TBI). During my PhD I investigated the potential of neuroimaging, blood, and behavioural biomarkers to provide reliable and objective insight into the pathophysiological changes that occur following TBI. Significant contributions included evidence supporting a relationship between TBI and the later development of a motor neuron disease-like process and the identification of novel MRI metrics sensitive to the axonal injury commonly seen in TBI. Furthermore, I showed that these MRI metrics, together with blood-based proteomics, were also sensitive to the subtle pathophysiological changes that occur following mild TBI. Importantly, I identified brain abnormalities beyond the resolution of neurocognitive deficits that are typically used to define recovery, which has important implications in the clinical management of mTBI, including guiding return-to-play decisions post-concussion.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Imaging
- Biomarkers
- MRI
- PET
- ct
- FLECT
- Image analysis
Collaborations and top research areas from the last five years
Projects
- 12 Finished
-
Translational platform for epilepsy therapy and biomarker discovery
Galanopoulou, A. S., Moshe, S., Mowrey, W. B., Branch, C., Fleysher, R., Cui , M., Staba, R. J., Mazarati, A., Sankar, R., Agoston, D., Duncan, D., Cabeen, R., Coles, L., O'Brien, T., Toga, A. W., Bragin, A., Engel, J., Vespa, P., Harris, N., Wright, D., Jones, N., Shultz, S., Casillas-Espinosa, P., Hudson, M., Ali, I. & Braine, E.
NIH - National Institutes of Health (United States of America)
15/04/22 → 31/03/23
Project: Research
-
The Glymphatic System: Novel Biomarker of Disease Severity and Therapeutic Target
1/03/22 → 1/03/24
Project: Research
-
Cellular therapeutics for neurorepair in multiple sclerosis
Petratos, S., Young, K., Lee, J. Y., Wong, N., Wright, D., Strittmatter, S. M. & Fehlings, M.
1/01/22 → 31/12/24
Project: Research
-
3D printer - Stratasys Objet30 Pro:
Kwan, P., O'Brien, T., Jones, N., Casillas-Espinosa, P., Hudson, M., Wright, D., Alan, T., French, C., Chan, J. & Jayawardena, A.
1/10/21 → 31/12/22
Project: Research
-
Measuring inflammation in brain and blood for predicting risk of post-traumatic epilepsy
Ali, I., Jones, N., O'Brien, T., Dedeurwaerdere, S., Wright, D. & Vivash, L.
United States Department of Defense (DOD)
30/09/21 → 29/06/24
Project: Research
-
A pre-existing Toxoplasma gondii infection exacerbates the pathophysiological response and extent of brain damage after traumatic brain injury in mice
Baker, T. L., Wright, D. K., Uboldi, A. D., Tonkin, C. J., Vo, A., Wilson, T., McDonald, S. J., Mychasiuk, R., Semple, B. D., Sun, M. & Shultz, S. R., 9 Jan 2024, In: Journal of Neuroinflammation. 21, 1, 31 p., 14.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Development of endothelial-targeted CD39 as a therapy for ischemic stroke
Lee, N. T., Savvidou, I., Selan, C., Calvello, I., Vuong, A., Wright, D. K., Brkljaca, R., Willcox, A., Chia, J. S. J., Wang, X., Peter, K., Robson, S. C., Medcalf, R. L., Nandurkar, H. H. & Sashindranath, M., Aug 2024, In: Journal of Thrombosis and Haemostasis. 22, 8, p. 2331-2344 14 p.Research output: Contribution to journal › Article › Research › peer-review
-
Inflammasomes at the crossroads of traumatic brain injury and post-traumatic epilepsy
Javalgekar, M., Jupp, B., Vivash, L., O’Brien, T. J., Wright, D. K., Jones, N. C. & Ali, I., Dec 2024, In: Journal of Neuroinflammation. 21, 1, 15 p., 172.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access1 Citation (Scopus) -
In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT-1 inhibitor E2730
Ali, I., Jupp, B., Hudson, M. R., Major, B., Silva, J., Yamakawa, G. R., Casillas-Espinosa, P. M., Braine, E., Thergarajan, P., Haskali, M. B., Vivash, L., Brkljaca, R., Shultz, S. R., Kwan, P., Fukushima, K., Sachdev, P., Cheng, J. Y., Mychasiuk, R., Jones, N. C., Wright, D. K., & 1 others , Nov 2024, In: Epilepsia. 65, 11, p. 3376-3390 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice
Keenan, R. J., Daykin, H., Metha, J., Cornthwaite-Duncan, L., Wright, D. K., Clarke, K., Oberrauch, S., Brian, M., Stephenson, S., Nowell, C. J., Allocca, G., Barnham, K. J., Hoyer, D. & Jacobson, L. H., Jan 2024, In: British Journal of Pharmacology. 181, 1, p. 87-106 20 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus)
Activities
- 1 Contribution to conference
-
Australian Synchrotron Users Meeting (ANSTO) [Virtual]
Anton Maksimento (Speaker), David Reser (Speaker), Daniel Hausermann (Speaker), Michael De Veer (Speaker), Olga Panagiotopoulou (Speaker), Charles Huveneers (Speaker), David Wright (Speaker) & Christopher Hall (Speaker)
2021Activity: Participating in or organising an event types › Contribution to conference
Equipment
-
Biomedical Imaging (MBI)
Kylie Reid (Manager), Robert Brkljaca (Manager), Christoph Hagemeyer (Other) & David Wright (Other)
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility